Does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol-producing phenotype?

Nutrition Reviews

Volumn 65, Issue 6, 2007, Pages 294-299

  Vatanparast, Hassanali ^a   Chilibeck, Philip D ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Bone; Equol; Menopause; Phytoestrogens; Soy

Indexed keywords

CALCIUM; DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; PHYTOESTROGEN; PLACEBO; PROGESTERONE; PROTEIN; VITAMIN D; ISOFLAVONE DERIVATIVE;

BONE; BONE METABOLISM; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; HUMAN; INTESTINE FLORA; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; POSTMENOPAUSE; REVIEW; SOYBEAN; SOYBEAN MILK; BIOSYNTHESIS; BONE DENSITY; CHEMISTRY; DRUG EFFECT; FEMALE; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS;

BONE DENSITY; FEMALE; GASTROINTESTINAL TRACT; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHENOTYPE; PHYTOESTROGENS; POSTMENOPAUSE; SOYBEANS;

EID: 34547162565     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2007.jun.294-299     Document Type: Review

References (42)

1. Cai DJ, Spence LA, Weaver CM. Soy isoflavone and bone health. In : New SA, Bonjour J-P, eds. Nutritional Aspects of Bone Health. Cambridge, UK : The Royal Society of Chemistry 2003 : 421 431.
2. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 288 : 321 333.
3. Ho SC, Chan SG, Yi Q., Wong E., Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001 16 : 1363 1369.
4. Somekawa Y., Chiquchi M., Ishibashi T., Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001 97 : 109 115.
5. Mei J., Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001 86 : 5217 5221.
6. Arjmandi BH, Getlinger MJ, Goyal NV, et al. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998 68 : 1358S 1363S.
7. Arjmandi BH, Alekel L., Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996 126 : 161 167.
8. Alekel DL, St. Germain S., Petersen CT, Hanson KB, Stewart JW. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimeno-pausal women. Am J Clin Nutr 2000 72 : 844 852.
9. Morabito N., Crisfulli A., Vergara C., et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002 17 : 1904 1912.
10. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipids and bone metabolism. Menopause 2001 8 : 259 265.
11. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998 1 : 124 129.
12. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isofla-vone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 2001 46 : 221 226.
13. Wangen KE, Duncan AM, Merz-Demlow BE, et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000 85 : 3043 3048.
14. Scheiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 2001 8 : 384 392.
15. Gallagher JC, Satpathy R., Rafferty K., Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause 2004 11 : 290 298.
16. Kreijkamp-Kaspers S., Kok L., Grobbee DE, de Haan EH, et al. Effect of soy protein containing isofla-vones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004 292 : 65 74.
17. Reinli K., Block G. Phytoestrogen content of foods - a compendium of literature values. Nutr Cancer 1996 26 : 123 148.
18. Heinonen SM, Hoikkala A., Wahala K., Adlercreutz H. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 2003 87 : 285 299.
19. Setchell KD. Absorption and metabolism of soy isoflavones - from food to dietary supplements and adults to infants. J Nutr 2000 130 : 654S 655S.
20. Day AJ, DuPont MS, Ridley S., et al. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett 1998 436 : 71 75.
21. Chang YC, Nair MG, Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod 1995 58 : 1892 1896.
22. Setchell KD, Brown NM, Desai PB, et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003 133 : 1027 1035.
23. Tsangalis D., Wilcox G., Shah NP, Stojanovska L. Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br J Nutr 2005 93 : 867 877.
24. Hur HG, Lay JO Jr., Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 2000 174 : 422 428.
25. Atkinson C., Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005 230 : 155 170.
26. Muthyala RS, Ju YH, Sheng S., et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004 12 : 1559 1567.
27. Mathey J., Mardon J., Fokialakis N., et al. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteoporos Int 2007 18 : 671 679.
28. Adlercreutz H., Honjo H., Higashi A., et al. Urinary excretion of lignans and isoflavonoid phytoestro-gens in Japanese men and women consuming a raditional Japanese diet. Am J Clin Nutr 1991 54 : 1093 1100.
29. Rowland IR, Wiseman H., Sanders TA, Adlercreutz H., Bowey EA. Inter-individual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut micro-flora. Nutr Cancer 2000 36 : 27 32.
30. Setchell KD, Cole SJ. Method of defining equolproducer status and its frequency among vegetarians. J Nutr 2006 136 : 2188 2193.
31. Wiseman H., Casey K., Bowey EA, et al. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 2004 80 : 692 699.
32. Frankenfeld CL, Atkinson C., Thomas WK, et al. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr 2005 94 : 873 876.
33. Kardinaal AF, Morton MS, Bruggemann-Rotgans IE, van Beresteijn EC. Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 1998 52 : 850 855.
34. Kim MK, Chung BC, Yu VY, et al. Relationships of urinary phyto-oestrogen excretion to BMD in post-menopausal women. Clin Endocrinol (Oxf) 2002 56 : 321 328.
35. Lydeking-Olsen E., Beck-Jensen JE, Setchell KD, Holm-Jensen T. Soy milk or progesterone for prevention of bone loss - a 2 year randomized, placebo-controlled trial. Eur J Nutr 2004 43 : 246 257.
36. Uesugi S., Watanabe S., Ishiwata N., Uehara M., Ouchi K. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. Biofactors 2004 22 : 221 228.
37. Bunout D., Barrera G., Leiva L., et al. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis. J Am Coll Nutr 2006 25 : 170 177.
38. Lee RD, Nieman DC. Nutritional Assessment. Boston : McGraw-Hill 2003.
39. Wu J., Oka J., Higuchi M., et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism 2006 55 : 423 433.
40. Ishimi Y., Yoshida M., Wakimoto S., et al. Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male mice. Bone 2002 31 : 180 185.
41. Wu J., Wang XX, Chiba H., et al. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J Appl Physiol 2003 94 : 335 342.
42. Albertazzi P., Steel SA, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Climacteric 2005 8 : 371 379.